Company Juno Therapeutics Inc
Equities
US48205A1097
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicole Keith
IRC | Investor Relations Contact | - | 15-06-30 |
Jonathan Biller
TRE | Treasurer | 61 | - |
Corporate Secretary | 48 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alles
BRD | Director/Board Member | 64 | - |
Peter Kellogg
BRD | Director/Board Member | 67 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,105,371 | 90,604,961 ( 78.04 %) | 0 | 78.04 % |
Company contact information
Juno Therapeutics, Inc.
400 Dexter Avenue North Suite 1200
98109, Seattle
+206-582-1600
http://junotherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |